• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Paperback

Series: Current Topics in Microbiology and Immmunology, Book 318

Medical Reference

ISBN10: 3642437834
ISBN13: 9783642437830
Publisher: Springer Nature
Published: Sep 25 2014
Pages: 362
Weight: 1.17
Height: 0.78 Width: 6.14 Depth: 9.21
Language: English

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.

Also in

Medical Reference